<DOC>
	<DOCNO>NCT01393041</DOCNO>
	<brief_summary>The purpose clinical study assess device deployment characteristic performance , well adverse event ( vascular complication ) SJM Angio-Seal VIP 6 French device utilize SJM collagen .</brief_summary>
	<brief_title>St. Jude Medical Angio-Seal VIP Vascular Closure Device</brief_title>
	<detailed_description />
	<criteria>1 . Patient undergoing diagnostic and/or interventional endovascular procedure via retrograde femoral arterial access . 2 . Patient legal age . 3 . Patient give write informed consent participation prior procedure . 4 . Patient willing undergo study procedure adhere data collection followup requirement . 1 . Patient unable provide write informed consent . 2 . Patient inability unwilling adhere data collection followup requirement . 3 . Patients pregnant lactate . 4 . Patient may participate another clinical trial potential impact hemostasis ( pharmaceutical/ device/ homeopathic ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
</DOC>